163 related articles for article (PubMed ID: 17258454)
1. Anti-mycobacterial activity of a bis-sulfonamide.
Wilkinson BL; Bornaghi LF; Wright AD; Houston TA; Poulsen SA
Bioorg Med Chem Lett; 2007 Mar; 17(5):1355-7. PubMed ID: 17258454
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents.
Owen DJ; Davis CB; Hartnell RD; Madge PD; Thomson RJ; Chong AK; Coppel RL; von Itzstein M
Bioorg Med Chem Lett; 2007 Apr; 17(8):2274-7. PubMed ID: 17303419
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity, structure and CMC relationships of alkanediyl alpha,omega-bis(dimethylammonium bromide) surfactants.
Laatiris A; El Achouri M; Infante MR; Bensouda Y
Microbiol Res; 2008; 163(6):645-50. PubMed ID: 17207986
[TBL] [Abstract][Full Text] [Related]
4. New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases.
Combrink KD; Denton DA; Harran S; Ma Z; Chapo K; Yan D; Bonventre E; Roche ED; Doyle TB; Robertson GT; Lynch AS
Bioorg Med Chem Lett; 2007 Jan; 17(2):522-6. PubMed ID: 17070048
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological screening of 2'-aryl/benzyl-2-aryl-4-methyl-4',5-bithiazolyls as possible anti-tubercular and antimicrobial agents.
Abhale YK; Sasane AV; Chavan AP; Deshmukh KK; Kotapalli SS; Ummanni R; Sayyad SF; Mhaske PC
Eur J Med Chem; 2015 Apr; 94():340-7. PubMed ID: 25778990
[TBL] [Abstract][Full Text] [Related]
6. 3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances.
Mahboobi S; Eichhorn E; Popp A; Sellmer A; Elz S; Möllmann U
Eur J Med Chem; 2006 Feb; 41(2):176-91. PubMed ID: 16375991
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of a novel series of 3-bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives--an extended structure-activity relationship study.
Mahboobi S; Eichhorn E; Winkler M; Sellmer A; Möllmann U
Eur J Med Chem; 2008 Mar; 43(3):633-56. PubMed ID: 17624634
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-mycobacterial activity of glycosyl sulfamides of arabinofuranose.
Suthagar K; Fairbanks AJ
Org Biomol Chem; 2016 Feb; 14(5):1748-54. PubMed ID: 26750606
[TBL] [Abstract][Full Text] [Related]
9. Studies on antibacterial agents. III. Synthesis of N,N'-bis(4-quinolyl-4-quinaldinyl-, 4-quinazolinyl-, or 9-acridinyl)polymethylenediamines and their sulfonamides.
Singh AK
Chem Pharm Bull (Tokyo); 1975 Aug; 23(8):1869-73. PubMed ID: 810252
[No Abstract] [Full Text] [Related]
10. Synthesis of arabinose glycosyl sulfamides as potential inhibitors of mycobacterial cell wall biosynthesis.
Suthagar K; Watson AJ; Wilkinson BL; Fairbanks AJ
Eur J Med Chem; 2015 Sep; 102():153-66. PubMed ID: 26263247
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of new diarylalkenes.
Gołebiewski WM; Cieniecka-Rosłonkiewicz A; Szybińska A
Pharmazie; 1999 Jan; 54(1):26-30. PubMed ID: 9987795
[TBL] [Abstract][Full Text] [Related]
12. Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
Batovska D; Parushev S; Stamboliyska B; Tsvetkova I; Ninova M; Najdenski H
Eur J Med Chem; 2009 May; 44(5):2211-8. PubMed ID: 18584918
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and antimicrobial activity of some new (sulfon-amidophenyl)-amide derivatives of N-(m-nitrobenzoyl)-D,L-methionine].
Pintilie O; Sunel V; Profire L; Pui A
Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):773-8. PubMed ID: 18293716
[TBL] [Abstract][Full Text] [Related]
14. A novel and efficient one step synthesis of 2-amino-5-cyano-6-hydroxy-4-aryl pyrimidines and their anti-bacterial activity.
Deshmukh MB; Salunkhe SM; Patil DR; Anbhule PV
Eur J Med Chem; 2009 Jun; 44(6):2651-4. PubMed ID: 19036478
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
Madikane VE; Bhakta S; Russell AJ; Campbell WE; Claridge TD; Elisha BG; Davies SG; Smith P; Sim E
Bioorg Med Chem; 2007 May; 15(10):3579-86. PubMed ID: 17368035
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus.
Ghorab MM; Ismail ZH; Abdalla M; Radwan AA
Arch Pharm Res; 2013 Jun; 36(6):660-70. PubMed ID: 23529860
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3, 4-thiadiazole-2-sulfonamide derivatives.
Gadad AK; Mahajanshetti CS; Nimbalkar S; Raichurkar A
Eur J Med Chem; 2000 Sep; 35(9):853-7. PubMed ID: 11006486
[TBL] [Abstract][Full Text] [Related]
18. Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.
Doundoulakis T; Xiang AX; Lira R; Agrios KA; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Appleman JR; Simonsen KB
Bioorg Med Chem Lett; 2004 Nov; 14(22):5667-72. PubMed ID: 15482944
[TBL] [Abstract][Full Text] [Related]
19. A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial.
Alvey L; Prado S; Huteau V; Saint-Joanis B; Michel S; Koch M; Cole ST; Tillequin F; Janin YL
Bioorg Med Chem; 2008 Sep; 16(17):8264-72. PubMed ID: 18752967
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of antibacterial chalcones.
Avila HP; Smânia Ede F; Monache FD; Smânia A
Bioorg Med Chem; 2008 Nov; 16(22):9790-4. PubMed ID: 18951808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
